1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

Recently released market study: Japan Pharmaceuticals & Healthcare Report Q3 2011

New Healthcare market report from Business Monitor International: "Japan Pharmaceuticals & Healthcare Report Q3 2011"

 
PRLog - Jun. 22, 2011 - BMI View: Japan's pharmaceutical market is entering a period of low-single digit growth. Demand for medicines will be supported by an ageing population, a high prevalence of chronic diseases and a welldeveloped network of prescribers, pharmacies and hospitals. However, the market will be constrained by anticipated austerity measures, affecting the public and private medical services sectors. We are increasingly positive about the generic drug sector and negative with regards to patented drugs.

Headline Expenditure Projections

*  Pharmaceuticals: JPY9,549bn (US$109.5bn) in 2010 to JPY9,654bn (US$109.7bn) in 2011; +1.1% in local currency terms and +0.2% in US dollar terms. Our forecast has been revised down from Q211 due to macroeconomic factors and additional analyst intervention.
 *  Healthcare: JPY 39,347bn (US$451bn) in 2010 to JPY39,568bn (US$450bn) in 2011; +0.6% in local currency terms and -0.4% in US dollar terms. Our forecast has been revised down from Q211 due to macroeconomic factors and additional analyst intervention.
 * Medical Devices: JPY 2,755bn (US$31.6bn) in 2010 to JPY2,814bn (US$32.0bn) in 2011; +2.1% in local currency terms and +1.2% in US dollar terms. Our forecast has been revised down from Q211 due to macroeconomic factors and additional analyst intervention.

------------------------------------------------------------
Full Report Details at
- http://www.fastmr.com/prod/171490_japan_pharmaceuticals_h...
------------------------------------------------------------


Business Environment Rating: Characterised by high rewards and low risks, Japan's pharmaceutical market remains the most attractive in Asia Pacific. The country scores highly for its preference for branded products, well-developed distribution sector, and large and ageing population. Drawbacks include increasing demand for generic medicines and relatively low healthcare spending as a percentage of GDP.

Key Trends & Developments

*  Following the Tohoku earthquake and tsunami, BMI determined that efficiencies needed to be realised in Japan's healthcare sector. We expect the government to further encourage the uptake of generic medicines. These products offer significant cost savings compared with originator brands, which have traditionally enjoyed strong demand from doctors and patients. Companies that will benefit from increased prescribing of generic medicines include Indian firms Ranbaxy Laboratories and Lupin, and domestic players such as Sawai Pharmaceuticals, Nichi-Iko Pharmaceutical, Towa Pharmaceutical, Nippon Chemiphar, Fuji Pharma and Taiyo Pharmaceutical.


BMI Economic View: Economic data for March 2011 has confirmed the negative effects of the recent earthquake and tsunami. The forecasts we made shortly after the crisis appear to be playing out right on cue, with consumer confidence falling, the trade surplus narrowing and price pressures increasing. We have also seen some repatriation of overseas equity holdings as expected, which has underpinned local bond yields. We stress, though, that long-dated Japanese government bonds (JGBs) are an extremely risky asset at these low yields given the macroeconomic shifts taking place at present, and we believe local equities hold more promise.

BMI Political View: Although the country's long-standing democratic credentials, lack of social tensions and stable security profile are all ratings-positive, its recent history of one-party dominance (and related nepotism) and recent turbulence in the upper echelons of government mean that the country fails to make the upper reaches of our global league table. Recent challenges to Prime Minister Naoto Kan's Democratic Party of Japan leadership in the aftermath of the Tohoku earthquake may lead to further short-term uncertainty, although we expect stability in the country's political system to be maintained.

Partial Table of Contents:

SWOT Analysis
- Japan Pharmaceuticals And Healthcare Industry SWOT
- Japan Political SWOT
- Japan Economic SWOT
Pharmaceutical Business Environment Ratings
- Table: Asia Pacific - Regional Pharmaceutical Business Environment Ratings, Q311
- Rewards
- Risks
Japan - Market Summary
- Regulatory Regime
- Recent Regulatory Developments
- Intellectual Property Developments
- Pricing and Reimbursement System
- Table: Reimbursement Categories And Rates
- Recent Pricing and Reimbursement Developments
- Other Regulatory Issues
- Table: Concerns Of Pharmaceutical Associations
Industry Trends and Developments
- Epidemiology
- Non-Communicable Diseases
- Communicable Diseases
- Mental Health
- Healthcare Sector
- Healthcare Sector Financing
- Healthcare Reforms
- International Reaction
- Medical Tourism
- Research and Development
- Clinical Trials
- Medical Devices
Industry Forecast Scenario
- Overall Market Forecast
- Table: Pharmaceutical Sales Indicators 2007-2015
- Key Growth Factors - Industry
- Table: Healthcare Expenditure Indicators 2007-2015
- Table: Government Healthcare Expenditure Indicators 2007-2015
- Table: Private Healthcare Expenditure Indicators 2007-2015
- Macroeconomic Outlook
- Table: Japan - Economic Activity
- Prescription Drug Market Forecast
- Table: Prescription Drug Sales Indicators 2007-2015
- Patented Drug Market Forecast
- Table: Patented Drug Market Indicators 2007-2015
- Generic Drug Market Forecast
- Table: Generic Drug Sales Indicators 2007-2015
- OTC Medicine Market Forecast
- Table: OTC Medicine Sales Indicators 2007-2015
- Medical Device Market Forecast
- Table: Medical Devices Sales Indicators 2007-2015
- Pharmaceutical Trade Forecast
- Table: Exports and Imports Indicators 2007-2015
- Other Healthcare Data
- Key Risks to BMI's Forecast Scenario
Competitive Landscape
- Pharmaceutical Industry
- Table: Top 20 Pharmaceutical Companies According To Market Capitalisation On The Tokyo Stock Exchange
- Foreign Generic Drug Sector
- Recent Pharmaceutical Company Developments
- Pharmaceutical Wholesale and Retail
Company Profiles
- Leading Local Manufacturers

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=1714...

About Business Monitor International

Business Monitor International (BMI) offers a comprehensive range of products and services designed to help senior executives, analysts and researchers assess and better manage operating risks, and exploit business opportunities, across 175 markets.  BMI offers three main areas of expertise: Country Risk BMI's country risk and macroeconomic forecast portfolio includes weekly financial market reports, monthly regional Monitors, and in-depth quarterly Business Forecast Reports.  Industry Analysis BMI covers a total of 17 industry verticals through a portfolio of services, including in-depth quarterly Country Forecast Reports.  View more research from Business Monitor International at http://www.fastmr.com/catalog/publishers.aspx?pubid=1010

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

# # #

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

--- End ---

Click to Share

Contact Email:
***@fastmr.com Email Verified
Source:Fast Market Research
Phone:1.800.844.8156
Zip:01267
Location:Massachusetts - United States
Industry:Health, Medical, Research
Tags:pharmaceutical, medicines, Healthcare, generic, intervention, dollar, currency, q211, revised, ageing
Shortcut:prlog.org/11553756
Verified Account Email Address
Verified Account Phone Number

Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “

More...

Trending News...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
9K2K1K
Click to Share